Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
120.07
-5.61 (-4.46%)
At close: Apr 28, 2026, 4:00 PM EDT
122.41
+2.34 (1.95%)
After-hours: Apr 28, 2026, 6:56 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $5.80 billion as of April 28, 2026. Its market cap has increased by 1,561.55% in one year.
Market Cap
5.80B
Enterprise Value
5.68B
1-Year Change
1,561.55%
Ranking
Category
Stock Price
$120.07
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $5.80B, an increase of 4,234.42%. That is a compound annual growth rate of 54.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 5.80B | 25.76% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.24B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 5.92B |
| Cogent Biosciences | 5.85B |
| PTC Therapeutics | 5.83B |
| Rhythm Pharmaceuticals | 5.75B |
| Mirum Pharmaceuticals | 5.74B |